Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) FECH Antibodies:
anti-Mouse (Murine) FECH Antibodies:
anti-Human FECH Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal FECH Primary Antibody for WB - ABIN2776936
Najahi-Missaoui, Dailey: Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases. in Blood 2005
Show all 2 Pubmed References
The plastidic type II ferrochelatase contains a C-terminal chlorophyll a/b (CAB (show NPDC1 Antibodies)) motif, a conserved hydrophobic stretch homologous to the CAB (show NPDC1 Antibodies) domain of plant light- harvesting proteins.
The apparent surplus of FeCH activity in the wild type is critical for cell viability under high light due to a regulatory role of FeCH in the distribution of Chl (show CHRDL1 Antibodies) into apoproteins.
Analysis of the recombinant full-length and truncated ferrochelatase (FeCH) demonstrated that the C-terminal extension is critical for activity of the FeCH and that it is strictly required for oligomerization of this enzyme.
5-aza-2'-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc (show MYC Antibodies) nuclear localization and binding to the E-boxes of transferrin receptor 1 (show TFR Antibodies) (TfR1 (show TFRC Antibodies)) and ferrochelatase (Fech) genes.
analysis of the inhibitory metal ion-binding site in ferrochelatase
Fech forms an oligomeric complex with Mfrn1 (show SLC25A37 Antibodies) and Abcb10 (show ABCB10 Antibodies) to synergistically integrate mitochondrial iron importation and use for heme biosynthesis.
Ferrochelatase activity and protein levels were dramatically decreased in Irp2(-/-) spleens, whereas ferrochelatase mRNA levels were increased, demonstrating posttranscriptional regulation of ferrochelatase in vivo
analysis of skin ferrochelatase and photosensitivity in mice and man
exon 10-deleted ferrochelatase heterozygous mice exhibited skin photosensitivity but no liver disease
analysis of the active site loop motif of murine ferrochelatase
hydrogen bonding between ferrochelatase and mesoporphyrin is a key factor in the thermodynamics of the binding reaction
Protoporphyric (Fech(m1pas)/Fech(m1pas) mice (C57BL/6J) showed a higher degree of liver pathology and more protoporphyrin accumulation than corresponding SJL/J and BALB/cJ mice. In the latter mice, mitochondrial respiratory chain activity was increased.
The kinetic mechanisms of inhibition of two variants of ferrochelatase by N-methylprotoporphyrin are reported.
the iron-removal reverse activity of FECH
In this study, QM/MM and quantum mechanical thermodynamic cycle perturbation free energy calculations were performed to investigate the porphyrin metalation in human ferrochelatase. It suggests a most reasonable pathway including the steps of the ferrous iron approaching from the site with Met76 coordinated and His263 playing the role of accepting proton.
These findings suggest that homozygous polymorphism of the FECH gene is associated with a slight elevation of the protoporphyrin level in erythrocytes, resulting in a mild EPP phenotype
a novel mutation, c.84G >A, in the FECH gene in four individuals with Erythropoietic Protoporphyria, is reported.
High ferrochelatase expression is associated with growth of malarial parasites in erythropoietic protoporphyria patients.
of ASO-V1 into developing human erythroblasts from an overtly EPP subject markedly increased the production of WT FECH mRNA and reduced the accumulation of PPIX to a level similar to that measured in asymptomatic EPP subjects
Sequence analysis of the FECH gene identified a novel missense mutation in exon 4 (c.418>A, G140R) of the FECH gene, as well as the common FECH IVS3-48 polymorphism in erythropoietic protoporphyria.
Loss-of-function FECH and gain-of-function erythroid-specific ALAS2 (show ALAS2 Antibodies) mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
The mutation analysis in the FECH gene identified different genotypes with the t/t genotype, 7 with the t/M genotype, 14 with the c/t genotype and 10 with c/M genotype from different EPP families.
Sequencing of the ferrochelatase gene did not show a mutation in any of the patients studied. Furthermore, the hypomorphic allele IVS3-48C was absent in all individuals.
Molecular dynamic simulations provided insight into the conformational movements and function of the active site residues of human ferrochelatase.
The protein encoded by this gene is localized to the mitochondrion, where it catalyzes the insertion of the ferrous form of iron into protoporphyrin IX in the heme synthesis pathway. Mutations in this gene are associated with erythropoietic protoporphyria. Two transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome 3.
, ferrochelatase, mitochondrial
, heme synthase
, heme synthetase
, protoheme ferro-lyase
, ATPase, Class I, type 8B, member 1